
    
      In each period of the randomized, two period crossover study, levoketoconazole will be
      administered orally as a single dose of 600 mg levoketoconazole to subjects in the fasted
      state or fed (at 30 minutes after beginning consumption of a standardized high-fat meal).
      Subjects assigned to one treatment in Period 1 will be assigned to the opposite treatment in
      Period 2.
    
  